Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02795013 · ClinicalTrials.gov registry record
Genetic Study of Families With High Frequency of Hodgkin Lymphoma
A clinical trial, sponsored by St. Jude Children's Research Hospital.
- Completed
- Registry status
- 27
- Enrollment target
NCT02795013 is a clinical trial that has completed, run by St. Jude Children's Research Hospital. The registered enrollment target is 27 participants.
The verdict
NCT02795013 has completed, sponsored by St. Jude Children's Research Hospital.
- COMPLETED
- Registry status
- 27 participants
- Enrollment target
Study Summary
Hodgkin lymphoma (HL) is a relatively rare disorder with known familiar aggregation (i.e. HL in more than one child, or parent and child). Because affected individuals in familial HL are genetically related, the existence of such families has long been considered as evidence in support of a genetic basis of HL susceptibility. However, it is largely unknown which genetic variations are responsible for recurring HL in families. Because the effects of genetic variants are likely to be strong in familial HL, identification of such variations will potentially reveal biological pathways critical to the pathogenesis of HL. PRIMARY OBJECTIVE: * To perform genome-wide sequencing of families with recurring Hodgkin lymphoma cases (affected as well as non-affected family members) to identify potential disease-causing germline genetic variations. SECONDARY OBJECTIVE: * To describe demographic and clinical features of the affected families.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2016-08-17 |
| Est. Completion | 2018-02-27 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02795013
The ClinicalTrials.gov registry entry for NCT02795013 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is St. Jude Children's Research Hospital, which has 410 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02795013 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02795013 about?
NCT02795013 is a clinical study titled "Genetic Study of Families With High Frequency of Hodgkin Lymphoma". Hodgkin lymphoma (HL) is a relatively rare disorder with known familiar aggregation (i.e. HL in more than one child, or parent and child). Because affected individuals in familial HL are genetically related, the existence of such families has long been considered as evidence in support of a genetic ...
What is the current status of trial NCT02795013?
This trial is currently completed. The enrollment target is 27 participants. The study started on 2016-08-17. Estimated completion is 2018-02-27.
Who is sponsoring clinical trial NCT02795013?
This trial is sponsored by St. Jude Children's Research Hospital, which has 410 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.